RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
In reply to 'The Myth of the Future Burden of CKD in United States'
Hoerger, T., Burrows, NR., & Pavkov, ME. (2015). In reply to 'The Myth of the Future Burden of CKD in United States'. American Journal of Kidney Diseases, 66(1), 172-172. https://doi.org/10.1053/j.ajkd.2015.05.003
In our AJKD article, we reported estimates of the future prevalence of CKD using existing definitions of the disease.1 In their letter, Drs Delanaye, El Nahas, and Glassock state that the high prevalence of CKD in persons aged 65 and older is primarily due to aging and does not represent an added mortality risk.2 A few studies have indeed found that estimated GFR values between 45 and 59?mL/min/1.73?m2 are not associated with increased mortality.3 However, other large epidemiologic studies have found that the relative and absolute risks of mortality are higher for the elderly with estimated GFR in this range than for the elderly with greater estimated GFR levels, even after controlling for albuminuria.
RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.